Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Probing and Enhancing Ligand-Mediated Active Targeting of Tumors Using Sub-5 nm Ultrafine Iron Oxide Nanoparticles

Theranostics(2020)10.7150/thno.39560Source: DataRank Database

Probing and Enhancing Ligand-Mediated Active Targeting of Tumors Using Sub-5 nm Ultrafine Iron Oxide Nanoparticles is a research paper published in Theranostics (2020). On theSindex it has a DataRank of 0. It has been cited 81 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access81 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: goldTopics (40)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Hui Wu ORCID,Jing Huang ORCID,Weiping Qian,Deborah E. Martinson,Bing Ji

Live enrichment

PubMed:32194814 PMC:PMC7052897

NCI NIH HHS

Grant: U01 CA198913

NCI NIH HHS

Grant: R01 CA154846

NCI NIH HHS

Grant: U01 CA151810

NCI NIH HHS

Grant: R01 CA202846

National Institutes of Health

Grant: 5R01CA154846-05

MRI Capable Receptor Targeted Drug Delivery for Pancreatic Cancer

National Institutes of Health

Grant: 5U01CA151810-05

Theranostic Nano particles for Targeted Treatment of Pancreatic Cancer

goldLicense: CC BY NC

publisherhttp://www.thno.org/v10p2479.htm

Unpaywallhttps://doi.org/10.7150/thno.39560

Europe_PMChttps://europepmc.org/articles/PMC7052897

Europe_PMChttps://europepmc.org/articles/PMC7052897?pdf=render

https://pubmed.ncbi.nlm.nih.gov/32194814

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Cell Line, TumorAnimalsMice, Inbred BALB CMiceMammary Neoplasms, ExperimentalTransferrinReceptors, TransferrinLigandsMolecular ProbesDrug Delivery SystemsParticle SizeFemaleMolecular ImagingOptical ImagingTheranostic NanomedicineMagnetic Iron Oxide Nanoparticles

Keywords

Molecular ImagingIron Oxide NanoparticlesDrug Delivery.Active TargetingEnhanced Permeability And RetentionMice, Inbred BALB COptical ImagingTransferrinMammary Neoplasms, ExperimentalLigandsTheranostic NanomedicineMiceDrug Delivery SystemsCell Line, TumorMolecular ProbesReceptors, TransferrinAnimalsFemaleMagnetic Iron Oxide NanoparticlesParticle SizeResearch Paper

Additional file 1 of A paclitaxel and microRNA-124 coloaded stepped cleavable nanosystem against triple negative breast cancer

10.6084/m9.figshare.14121575.v1figshare

Additional file 1 of A paclitaxel and microRNA-124 coloaded stepped cleavable nanosystem against triple negative breast cancer

10.6084/m9.figshare.14121575figshare